Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2009; Volume 195, Supplement 667
XXXV Congress of The Spanish Society for Physiological Sciences
2/17/2009-2/20/2009
Valencia, Spain


PREVENTION OF AGE-DEPENDENT OXIDATIVE DAMAGE AND INFLAMMATION BY CHRONIC MELATONIN ADMINISTRATION
Abstract number: O12

Escames1 G, Lopez1 LC, Serrano1 E, Ozturk1 G, Garcia1 L, Acuna-Castroviejo1 D

1Centro de Investigacin Biomdica, Parque Tecnolgico de Ciencias de la Salud, Universidad de Granada, 18100 Armilla, Granada, Spain. [email protected]

Aims: 

Increasing evidence supports the participation of melatonin in the organism defense against oxidative stress. Thus, we investigated whether chronic melatonin administration prevents mitochondrial oxidative stress and affects life span in mice.

Methods: 

Brain mitochondria from female senescent prone (SAMP8) and resistant (SAMR1) mice at 5 and 10 months of age were studied. Mitochondrial oxidative stress was determined by the levels of lipid peroxidation, glutathione and glutathione disulfide, and glutathione peroxidase and reductase activities. Mitochondrial function was assessed by the activity of the respiratory chain complexes and the ATP content.

Results: 

Chronic melatonin administration to SAMP8 mice prevented the age-dependent brain mitochondrial oxidative stress and the bioenergetic failure, increasing the ATP production. Melatonin administration also counteracted the age-dependent increase in circulating pro-inflammatory cytokines such as TNFa and INFg, and nitric oxide levels. Melatonin increased both half-life and longevity by 25%, mainly in SAMP8 group.

Conclusions: 

These results suggest an age-related increase in brain mitochondria vulnerability to oxidation in SAM mice at 10 months of age that was counteracted by melatonin therapy. The effects of melatonin on mitochondrial physiology probably underline the ability of the indoleamine to increase maximal life span in these animals.

Supported in part by grants: RD06/0013/0008 (RETICEF) and CTS-101

To cite this abstract, please use the following information:
Acta Physiologica 2009; Volume 195, Supplement 667 :O12

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE